Gossamer Bio.
Gossamer Bio. , changes, %
Gossamer Bio (GOSS) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | -647.2% | 55.4% | -296.4% | -50.6% | |||
Changes by years, y/y, % | ||||||||
Changes by quarters, q/q, % | +647pp | -352pp |